CN103330806B - Drug for treatment of rheumatoid arthritis - Google Patents
Drug for treatment of rheumatoid arthritis Download PDFInfo
- Publication number
- CN103330806B CN103330806B CN201310278995.3A CN201310278995A CN103330806B CN 103330806 B CN103330806 B CN 103330806B CN 201310278995 A CN201310278995 A CN 201310278995A CN 103330806 B CN103330806 B CN 103330806B
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- radix
- herba
- rheumatoid arthritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a drug for treatment of rheumatoid arthritis. The drug is characterized in that it is made of the following raw medicinal materials by weight: 1-3 parts of peach kernels, 2-4 parts of Eucommia ulmoides, 1-5 parts of rhizoma curculiginis, 3-6 parts of long-noded pit viper, 2-5 parts of papayas, 1-6 parts of rhizoma drynariae, 5-8 parts of Radix Astragali, 1-4 parts of spina date seeds, 2-5 parts of Rhodiola rosea, 2-6 parts of asarum, 1-3 parts of myrrh, 3-5 parts of donkey-hide gelatin, 1-4 parts of safflower, 2-5 parts of radix angelicae, 1-6 parts of pyrola, 2-5 parts of black sesame seeds, 1-9 parts of Chinese yam, 1-4 parts of Poria cocos, 1-3 parts of radix sileris, 2-5 parts of notopterygium roots, 2-4 parts of honeysuckle, 1-6 parts of Ligusticum wallichii, 1-3 parts of Salvia miltiorrhiza, 3-5 parts of Lycopodium clavatum, and 1-5 parts of Polygonum cuspidatum. The drug provided in the invention can effectively treat arthralgia and inconvenient flexion and extension caused by rheumatoid arthritis, and also can treat lumbar disc herniation, hyperosteogeny, sciatica and other diseases at the same time.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of rheumatoid arthritis.
Background technology
At present, rheumatoid arthritis is a great problem of current rheumatism subject, the morbidity of rheumatoid arthritis is mainly relevant with the factor such as infection, immunity, metabolism, endocrine, environment, heredity, clinical main manifestations is arthralgia, swelling, moving obstacle, and severe patient can occur that disable in joint and viscera function exhaustion.Rheumatoid arthritis affects that wrist, the palm refer to, the little joint such as proximal interphalangeal joint more, is a plurality of symmetrical, cuts sharp ache, often has stiff phenomenon in morning.This sick types of drugs of clinical treatment is various, although have antiinflammatory action, antiallergic action, calmness, analgesic activity, improve microcirculation, side effect is large, is not suitable for patient's long-term taking.
Summary of the invention
The object of the invention is to solve above-mentioned the deficiencies in the prior art, the compound Chinese medicinal preparation of the treatment rheumatoid arthritis of a kind of evident in efficacy, safe, inexpensive, dispelling wind and removing obstruction in the collateral, expelling wind and removing dampness, dispersing cold for relieving pain, nourshing blood and promoting blood circulation, stasis-dispelling and pain-killing, removing dampness circulation of qi promoting is provided.
The present invention relates to a kind of Chinese medicine preparation for the treatment of rheumatoid arthritis, it is characterized in that being made by the raw material of Chinese medicine of following parts by weight: Semen Persicae 1-3 part, Cortex Eucommiae 2-4 part, Rhizoma Curculiginis 1-5 part, Agkistrodon 3-6 part, Fructus Chaenomelis 2-5 part, Rhizoma Drynariae 1-6 part, Radix Astragali 5-8 part, Semen Ziziphi Spinosae 1-4 part, Radix Rhodiolae 2-5 part, Herba Asari 2-6 part, Myrrha 1-3 part, Colla Corii Asini 3-5 part, Flos Carthami 1-4 part, Radix Angelicae Dahuricae 2-5 part, Herba Pyrolae 1-6 part, Semen Sesami Nigrum 2-5 part, Rhizoma Dioscoreae 1-9 part, Poria 1-4 part, Radix Saposhnikoviae 1-3 part, Rhizoma Et Radix Notopterygii 2-5 part, Flos Lonicerae 2-4 part, Rhizoma Chuanxiong 1-6 part, Radix Salviae Miltiorrhizae 1-3 part, Herba Lycopodii 3-5 part, Rhizoma Polygoni Cuspidati 1-5 part, particularly preferably: 2 parts, Semen Persicae, 2 parts of the Cortexs Eucommiae, 1 part of Rhizoma Curculiginis, 3 parts of Agkistrodons, 2 parts of Fructus Chaenomeliss, 1 part of Rhizoma Drynariae, 5 parts of the Radixs Astragali, 2 parts of Semen Ziziphi Spinosaes, 2 parts of Radix Rhodiolaes, 3 parts of Herba Asaris, 1 part of Myrrha, 3 parts, Colla Corii Asini, 2 parts, Flos Carthami, 3 parts of the Radixs Angelicae Dahuricae, 1 part of Herba Pyrolae, 3 parts of Semen Sesami Nigrums, 2 parts of Rhizoma Dioscoreaes, 2 parts, Poria, 1 part of Radix Saposhnikoviae, 2 parts of Rhizoma Et Radix Notopterygiis, 2 parts of Flos Loniceraes, 4 parts of Rhizoma Chuanxiongs, 2 parts of Radix Salviae Miltiorrhizaes, 3 parts of Herba Lycopodiis, 1 part of Rhizoma Polygoni Cuspidati.
Manufacture method of the present invention: by Semen Persicae, the Cortex Eucommiae, Rhizoma Curculiginis, Agkistrodon, Fructus Chaenomelis, Rhizoma Drynariae, the Radix Astragali, Semen Ziziphi Spinosae, Radix Rhodiolae, Herba Asari, Myrrha, Colla Corii Asini, Flos Carthami, the Radix Angelicae Dahuricae, Herba Pyrolae, Semen Sesami Nigrum, Rhizoma Dioscoreae, Poria, Radix Saposhnikoviae, Rhizoma Et Radix Notopterygii, Flos Lonicerae, Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, Herba Lycopodii, Rhizoma Polygoni Cuspidati by the proportioning mix homogeneously of getting it filled, pulverized 60-100 mesh sieve, can be made into routinely powder, or add routinely adjuvant and make honeyed pill, water pill, the present invention is preferably powder, after being ground into the Chinese medicine powder sterilizing of smalls, incapsulate 0.45 gram of every capsules.
Instructions of taking: every day, oral drug dose was 4.05 grams, every bu early, middle and late three times oral, each 3.
Medicine of the present invention has the effect of expelling wind and removing dampness, blood circulation promoting and blood stasis dispelling, removing obstruction in the collateral to relieve pain, can effectively treat arthralgia and joint stuffiness that rheumatoid joint causes, simultaneously, can also treat the diseases such as prolapse of lumbar intervertebral disc, hyperosteogeny, sciatica, there is the advantages such as evident in efficacy, safe, inexpensive, dispelling wind and removing obstruction in the collateral, expelling wind and removing dampness, dispersing cold for relieving pain, nourshing blood and promoting blood circulation, stasis-dispelling and pain-killing, removing dampness circulation of qi promoting.
The clinical efficacy for the treatment of rheumatism atrophic arthritis is summed up:
One, physical data
Through 7900 routine clinical treatments, rheumatic sufferers 6937 examples wherein, rheumatoid patient 963 examples, simultaneously with 816 examples that have of prolapse of lumbar intervertebral disc, with 1197 examples that have of hyperosteogeny.
Two, diagnostic criteria
Arthralgia, swelling, severe patient ankylosis, deformity and dysfunction, lab testing, erythrocyte sedimentation rate, rheumatoid factor, x-ray inspection etc. can be made a definite diagnosis.
Three, instructions of taking
Take compound preparation of the present invention, early, middle and late three times of every bu, each 3 one month is a course for the treatment of.
Four, efficacy assessment standard:
Cure arthralgia, swelling disappears, and recovers activities.
Improvement arthralgia, swelling alleviates, and joint movement function improves.
Do not heal symptom and sign without improvement.
Five, therapeutic effect
A month course for the treatment of, a course for the treatment of of the lighter, severe one can take a turn for the better or cure two to three courses for the treatment of.
In 7900 routine patients, cure 6356 examples, 1544 examples that take a turn for the better, cure rate 80.5%, improvement rate 19.5%, effective percentage 100%.
Six, model case
1. patient Wang Xue, female, 38 years old, Gu Mo people from village, Weihai City, main suit's both hands arthralgia, more than swelling March, through municipal hospital, be diagnosed as rheumatic arthritis, once the medicine such as oral diclofenac sodium, indometacin, after drug withdrawal, pain recurs again, take a course for the treatment of of the present invention, symptom disappears completely, follows up a case by regular visits to not recurrence in a year.
2. patient Liu Lichen, man, 48 years old, grass mausoleum, Weihai City Ziren, main suit's finger-joint pain 3 years, more than a year with prolapse of lumbar intervertebral disc simultaneously, in Weihai, various big hospital was all once treated, last or take and take analgesic as main, lumbago and joints of hand hurt like hell again after drug withdrawal, upon somebody's introduction, starting to take one of this product symptom course for the treatment of obviously improves, after continue to take two courses for the treatment of, symptom disappears completely, be recurrence existing half a year.
3. patient Miao Fengji, man, 56 years old, people from urban district, Weihai, main suit's joints of hand, the gonalgia are many half a year, knee joint swelling simultaneously, from taking indometacin, effect is general at ordinary times, carry out upon somebody's introduction my treatment, take a course for the treatment of of the present invention, symptom again from having taken a course for the treatment of, does not recur after disappearing completely so far.
The specific embodiment
Embodiment 1: get Semen Persicae 2g, Cortex Eucommiae 2g, Rhizoma Curculiginis 1g, Agkistrodon 3g, Fructus Chaenomelis 2g, Rhizoma Drynariae 1g, Radix Astragali 5g, Semen Ziziphi Spinosae 2g, Radix Rhodiolae 2g, Herba Asari 3g, Myrrha 1g, Colla Corii Asini 3g, Flos Carthami 2g, Radix Angelicae Dahuricae 3g, Herba Pyrolae 1g, Semen Sesami Nigrum 3g, Rhizoma Dioscoreae 2g, Poria 2g, Radix Saposhnikoviae 1g, Rhizoma Et Radix Notopterygii 2g, Flos Lonicerae 2g, Rhizoma Chuanxiong 4g, Radix Salviae Miltiorrhizae 2g, Herba Lycopodii 3g, Rhizoma Polygoni Cuspidati 1g, by after these Chinese medicine mix homogeneously, pulverized 60-100 mesh sieve, can be made into routinely powder, or add routinely adjuvant and make honeyed pill, water pill, every day, oral drug dose was 4.05 grams, every bu early, in, evening three times oral, each 1.35 grams, one after each meal, the present invention preferably makes powder by medicine, after sterilizing, incapsulate, 0.45 gram every, every bu early, in, evening three times oral, each 3, one after each meal.
Claims (2)
1. a medicine for the treatment of rheumatoid arthritis, it is characterized in that being made by the raw material of Chinese medicine of following parts by weight: Semen Persicae 1-3 part, Cortex Eucommiae 2-4 part, Rhizoma Curculiginis 1-5 part, Agkistrodon 3-6 part, Fructus Chaenomelis 2-5 part, Rhizoma Drynariae 1-6 part, Radix Astragali 5-8 part, Semen Ziziphi Spinosae 1-4 part, Radix Rhodiolae 2-5 part, Herba Asari 2-6 part, Myrrha 1-3 part, Colla Corii Asini 3-5 part, Flos Carthami 1-4 part, Radix Angelicae Dahuricae 2-5 part, Herba Pyrolae 1-6 part, Semen Sesami Nigrum 2-5 part, Rhizoma Dioscoreae 1-9 part, Poria 1-4 part, Radix Saposhnikoviae 1-3 part, Rhizoma Et Radix Notopterygii 2-5 part, Flos Lonicerae 2-4 part, Rhizoma Chuanxiong 1-6 part, Radix Salviae Miltiorrhizae 1-3 part, Herba Lycopodii 3-5 part, Rhizoma Polygoni Cuspidati 1-5 part.
2. medicine as claimed in claim 1, it is characterized in that being made by the raw material of Chinese medicine of following parts by weight: 2 parts, Semen Persicae, 2 parts of the Cortexs Eucommiae, 1 part of Rhizoma Curculiginis, 3 parts of Agkistrodons, 2 parts of Fructus Chaenomeliss, 1 part of Rhizoma Drynariae, 5 parts of the Radixs Astragali, 2 parts of Semen Ziziphi Spinosaes, 2 parts of Radix Rhodiolaes, 3 parts of Herba Asaris, 1 part of Myrrha, 3 parts, Colla Corii Asini, 2 parts, Flos Carthami, 3 parts of the Radixs Angelicae Dahuricae, 1 part of Herba Pyrolae, 3 parts of Semen Sesami Nigrums, 2 parts of Rhizoma Dioscoreaes, 2 parts, Poria, 1 part of Radix Saposhnikoviae, 2 parts of Rhizoma Et Radix Notopterygiis, 2 parts of Flos Loniceraes, 4 parts of Rhizoma Chuanxiongs, 2 parts of Radix Salviae Miltiorrhizaes, 3 parts of Herba Lycopodiis, 1 part of Rhizoma Polygoni Cuspidati.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310278995.3A CN103330806B (en) | 2013-07-04 | 2013-07-04 | Drug for treatment of rheumatoid arthritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310278995.3A CN103330806B (en) | 2013-07-04 | 2013-07-04 | Drug for treatment of rheumatoid arthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103330806A CN103330806A (en) | 2013-10-02 |
| CN103330806B true CN103330806B (en) | 2014-04-02 |
Family
ID=49239056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310278995.3A Expired - Fee Related CN103330806B (en) | 2013-07-04 | 2013-07-04 | Drug for treatment of rheumatoid arthritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103330806B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103550741A (en) * | 2013-10-31 | 2014-02-05 | 谢坤 | Traditional Chinese medicinal preparation for treating rheumatism |
| CN103735848B (en) * | 2014-01-24 | 2016-04-20 | 袁延光 | A kind of Chinese medicine preparation and preparation method for the treatment of hyperosteogeny |
| CN104189357A (en) * | 2014-08-18 | 2014-12-10 | 杨海林 | Traditional Chinese medicine ointment for treating rheumatoid arthritis |
| CN104524077A (en) * | 2014-12-22 | 2015-04-22 | 蒋亚静 | Traditional Chinese medicine capsule for treating sciatica and preparation method of traditional Chinese medicine capsule |
| CN104840624A (en) * | 2015-05-27 | 2015-08-19 | 石汝花 | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof |
| CN107184648A (en) * | 2017-06-02 | 2017-09-22 | 广州智润生物制药科技有限公司 | It is a kind of to treat patch of protrusion of lumber intervertebral disc and preparation method thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101450184B (en) * | 2007-12-06 | 2011-01-19 | 陈振山 | Plaster for treating rheumatism bone disease |
| CN101632745B (en) * | 2009-09-08 | 2012-05-23 | 丛大龙 | Traditional Chinese medical compound preparation for treating rheumatism and rheumatoid arthritis |
| CN102366602A (en) * | 2011-10-21 | 2012-03-07 | 铜仁市舒心科技有限责任公司 | Traditional Chinese medicine formula used for treating rheumatism |
-
2013
- 2013-07-04 CN CN201310278995.3A patent/CN103330806B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103330806A (en) | 2013-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102920984B (en) | Medicine for curing rheumatoid arthritis | |
| CN103330806B (en) | Drug for treatment of rheumatoid arthritis | |
| CN104547790A (en) | Traditional Chinese medicine composition for treating rheumatic arthritis and preparation method thereof | |
| CN102940853B (en) | Navel paste for treating mammary gland hyperplasia diseases | |
| CN103356877A (en) | Traditional Chinese medicine composition for treating orthopedic diseases | |
| CN102973862A (en) | Chinese medicine preparation for treating skin itch | |
| CN103055278A (en) | Medicament for treating rheumatism | |
| CN102688387B (en) | Medicine for treating subacute thyroiditis | |
| CN101856445A (en) | Chinese patent medicament pills for treating femoral head necrosis | |
| CN101632745B (en) | Traditional Chinese medical compound preparation for treating rheumatism and rheumatoid arthritis | |
| CN104474473A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation and preparation method thereof | |
| CN103251766A (en) | Chinese medicine composition, and clinical preparation and preparation method thereof | |
| CN103316296B (en) | Traditional Chinese medicine composition for treating hyperostosis | |
| CN102755571A (en) | Medicinal liquor and preparation process for treating rheumatism and rheumatoid | |
| CN102406870B (en) | Medicament for treating rheumatic arthralgia | |
| CN103690621B (en) | Traditional Chinese medicine decoction for treating scapulohumeral periarthritis | |
| CN103585273B (en) | Traditional Chinese medicine composition for treating local swelling and pain | |
| CN103041362B (en) | Drug for treating rheumatism and rheumatoid and preparation method thereof | |
| CN101912570B (en) | Medicinal composition for treating rheumatism and preparation method thereof | |
| CN105535333A (en) | Traditional Chinese medicine composition and preparation for treating lymphatic lesions, as well as preparation method and application thereof | |
| CN104971332A (en) | Traditional Chinese medicine for treating hemorrhoids | |
| CN103349767B (en) | Inula nervosa Wall oil capsule preparation and preparation method thereof | |
| CN103816505A (en) | Medicine for treating disease of prostate | |
| CN103877239A (en) | Chinese medicinal composition for treating rheumatism and rheumatoid arthritis and preparation method and application thereof | |
| CN101361934B (en) | Traditional Chinese medicine preparation for treating arthritis and various osteonosus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140402 Termination date: 20150704 |
|
| EXPY | Termination of patent right or utility model |